GlassScriptPhysician profile
Crystal I Tuncay
NPI 1992790414
$32,946.85
in general payments reported to CMS, 2019-2025
62 companies · $2,101 in 2025
The $2,101 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,888 · 2020: $4,713 · 2021: $15K · 2022: $4,335 · 2023: $2,524 · 2024: $2,319 · 2025: $2,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,944.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13,608.61 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Allergan, INC. | $5,958.71 | 2019-2021 | |
| Amgen INC. | $2,354.97 | 2019-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $1,729.52 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $1,240.97 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $665.42 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $574.94 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $573.03 | 2021-2025 | |
| Astellas Pharma US INC | $517.21 | 2019-2024 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $489.85 | 2019-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $446.93 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Pfizer INC. | $331.72 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $330.92 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $305.22 | 2022-2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $279.40 | 2019-2023 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $252.26 | 2024-2025 | Auvelity |
| Glaxosmithkline, LLC. | $236.37 | 2020-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Takeda Pharmaceuticals U.S.A., INC. | $228.25 | 2019-2023 | Trintellix |
| Amarin Pharma, INC. | $214.62 | 2019-2022 | |
| Mylan Specialty L.P. | $183.55 | 2019-2023 | Yupelri |
| Ibsa Pharma INC. | $180.25 | 2020-2023 | Tirosint, Licart |
| Dexcom, INC. | $158.29 | 2021-2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $150.05 | 2019-2021 | |
| Heartflow, INC. | $125.00 | 2025 | |
| Vanda Pharmaceuticals INC. | $121.51 | 2021-2025 | Fanapt |
| Esperion Therapeutics, INC. | $120.35 | 2020-2022 | |
| Phathom Pharmaceuticals, INC. | $106.76 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $105.64 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $104.44 | 2022 | |
| Vifor Pharma, INC. | $101.09 | 2019-2021 | |
| Lundbeck LLC | $100.39 | 2020-2025 | Rexulti |
| Idorsia Pharmaceuticals US INC | $77.25 | 2022-2024 | Quviviq |
| Radius Health, INC. | $67.15 | 2024-2025 | Tymlos |
| Insulet Corporation | $62.60 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $61.64 | 2020-2024 | |
| Regeneron Healthcare Solutions, INC. | $58.54 | 2019 | |
| Edwards Lifesciences Corporation | $56.85 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biohaven Pharmaceuticals, INC. | $55.44 | 2021 | |
| Alkermes, INC. | $55.28 | 2021 | |
| Xeris Pharmaceuticals, INC. | $50.00 | 2023-2024 | Gvoke Hypopen |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $49.76 | 2024-2025 | Rexulti |
| Arbor Pharmaceuticals, INC. | $48.58 | 2019-2021 | |
| Abbott Laboratories | $39.52 | 2023-2024 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $37.40 | 2019-2022 | |
| Vivus LLC | $30.46 | 2019-2021 | |
| Tactile Systems Technology INC | $27.82 | 2024 | Entre Plus, Flexitouch Plus |
| Nevro Corp. | $26.75 | 2024 | Senza |
| Sumitomo Pharma America, INC. | $22.96 | 2023 | Gemtesa |
| Ultragenyx Pharmaceutical INC. | $22.86 | 2024 | Crysvita |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.83 | 2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $17.72 | 2022 | |
| Azurity Pharmaceuticals, INC. | $17.10 | 2024 | |
| Amneal Pharmaceuticals LLC | $16.74 | 2024 | Unithroid |
| Halozyme INC | $16.23 | 2023 | |
| Bausch Health US, LLC | $16.15 | 2019 | |
| Alfasigma USA, INC. | $14.96 | 2021 | |
| Sanofi Pasteur INC. | $14.79 | 2023 | |
| Genentech USA, INC. | $14.73 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.44 | 2021 | |
| Shire North American Group INC | $12.81 | 2019 | |
| Eisai INC. | $12.04 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Tuncay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.